"Benzalkonium Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics.
| Descriptor ID |
D001548
|
| MeSH Number(s) |
D02.092.877.096.040 D02.675.276.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Benzalkonium Compounds".
Below are MeSH descriptors whose meaning is more specific than "Benzalkonium Compounds".
This graph shows the total number of publications written about "Benzalkonium Compounds" by people in this website by year, and whether "Benzalkonium Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Benzalkonium Compounds" by people in Profiles.
-
Keratinocyte-specific deletion of the IL-6R? exacerbates the inflammatory response during irritant contact dermatitis. Toxicology. 2019 07 01; 423:123-131.
-
Associations Between Immune Phenotype and Inflammation in Murine Models of Irritant Contact Dermatitis. Toxicol Sci. 2019 03 01; 168(1):179-189.
-
Transcriptional profiling of irritant contact dermatitis (ICD) in a mouse model identifies specific patterns of gene expression and immune-regulation. Toxicology. 2018 12 01; 410:1-9.
-
IL-6 deficiency exacerbates skin inflammation in a murine model of irritant dermatitis. J Immunotoxicol. 2013 Apr-Jun; 10(2):192-200.
-
Listeria monocytogenes strains selected on ciprofloxacin or the disinfectant benzalkonium chloride exhibit reduced susceptibility to ciprofloxacin, gentamicin, benzalkonium chloride, and other toxic compounds. Appl Environ Microbiol. 2011 Dec; 77(24):8714-21.
-
Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones. Adv Ther. 2009 Apr; 26(4):447-54.
-
The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Jpn J Ophthalmol. 1996; 40(2):212-9.